5h

For investors following the increasingly competitive obesity drug market, today delivered another reminder of why Eli Lilly continues attracting so much attention. Shares climbed to record levels after the company unveiled new clinical data that appears to reinforce its position near the top of one of healthcare’s fastest growing markets. The reaction was immediate. Investors […] The post Eli Lilly stock hits fresh highs after critical drug results appeared first on Rolling Out .